Literature DB >> 35043279

Decline in hospitalization rates for herpes zoster in Italy (2003-2018): reduction in the burden of disease or changing of hospitalization criteria?

Emanuele Amodio1, Alessandro Marrella2, Alessandra Casuccio2, Francesco Vitale2.   

Abstract

BACKGROUND: Herpes Zoster (HZ) is a very demanding disease caused by the reactivation of latent Varicella Zoster Virus. The main aim of this study was to estimate the burden of the HZ hospitalizations in Italy from 2003 to 2018 evaluating temporal trends.
METHODS: Retrospective population-based study analyzing Hospital Discharge Records. Hospitalization records reporting the ICD-9 CM 053.X code in the principal diagnosis or in any of the five secondary diagnoses were considered as cases. Trends of hospitalization rates have been evaluated by Joinpoint analyses.
RESULTS: Overall, 99,036 patients were hospitalized with HZ in the 16-year period of the study, and 83,720 (84.5%) of these patients were over 50 years. Hospitalization rate was 10.4 per 100,000 persons/year with a significant decreasing trend from 13.9 in 2003-2006 to 7.8 in 2015-2018 (p < 0.001). Hospitalization rates showed a 20-fold higher risk among subjects aged over 80 years and 11-fold higher risk among 70-79-year-old subjects with respect to those aged less than 50 years. Over time, a statistically significant increase was observed for the case fatality rate (from 1.2 to 1.7%; p < 0.001) and the median length of stay (from 7 to 8 days; p < 0.001).
CONCLUSIONS: Zoster is a disease that causes hospitalization as relatively frequent complication and the observed reduced trend over time could be due to a restriction in hospitalization criteria instead of a reduced burden of disease. The decreasing trend should be carefully interpreted, since it could have an impact on promoting herpes zoster vaccination.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Herpes zoster; Hospitalization; Italy

Mesh:

Year:  2022        PMID: 35043279     DOI: 10.1007/s40520-021-02014-7

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  3 in total

1.  Epidemiology and costs of herpes zoster: background data to estimate the impact of vaccination.

Authors:  Valeria Di Legami; Maria Michela Gianino; Marta Ciofi degli Atti; Marco Massari; Alessandro Migliardi; Gianpaolo Scalia Tomba; Carla Zotti
Journal:  Vaccine       Date:  2007-08-15       Impact factor: 3.641

2.  Burden of herpes zoster requiring hospitalization in Spain during a seven-year period (1998-2004).

Authors:  Angel Gil; Ruth Gil; Alejendro Alvaro; María San Martín; Antonio González
Journal:  BMC Infect Dis       Date:  2009-05-07       Impact factor: 3.090

Review 3.  Systematic review of incidence and complications of herpes zoster: towards a global perspective.

Authors:  Kosuke Kawai; Berhanu G Gebremeskel; Camilo J Acosta
Journal:  BMJ Open       Date:  2014-06-10       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.